Carleton McKenna Advises Research Organics in its Sale to Sigma Aldrich

Carleton McKenna & Co. acted as exclusive financial advisor to Research Organics, Inc. in its sale to Sigma-Aldrich Corporation. Sigma-Aldrich acquired Research Organics to expand the company's buffer production capacity and to increase its portfolio of pharma-grade raw materials for the biopharmaceutical and diagnostic markets.

"Research Organics is an important addition to our pharmaceutical-grade portfolio of raw materials for the biopharmaceutical industry," says Gilles Cottier, EVP, Sigma-Aldrich, and President, SAFC. "This acquisition is an outstanding complement to our existing raw materials portfolio and will help us provide more innovative solutions for some of our customers' toughest supply challenges. It will also enable us to provide SAFC's customers with true dual sourcing of buffers from two of the world's leading manufacturing sites."

Robert Sternfeld, President and Chief Executive Officer of Research Organics said, "The team at Carleton McKenna did an outstanding job in advising us throughout the process and achieving a valuation that exceeded expectations. Their team members were helpful, responsive and ensured that we successfully closed the transaction. This combination with Sigma represents the best strategic outcome for our company and its owners."

About Research Organics, Inc.

Founded in the 1950s and headquartered in Cleveland, Ohio, Research Organics is a supplier of high purity biochemicals for use in molecular biology, diagnostics, cell culture, pharmaceuticals, biopharmaceuticals, life sciences and biotechnology.

About Sigma-Aldrich Corporation

St. Louis-based Sigma-Aldrich Corp. (NASDAQ: SIAL) is a life-science and specialty chemical company that develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment worldwide.It operates in 40 countries, has nearly 9,000 employees and had over $2.5 billion in sales in 2012.

About Carleton McKenna & Co.

For more than thirty years, Carleton McKenna & Co. and its predecessor firms have been providing merger and acquisition advisory, capital raising and valuation services for small to mid-cap regional clients – both public and private – with expertise across a broad array of industries. For further information about Carleton McKenna & Co., please visit www.carletonmckenna.com.

If you would like more information about this transaction, please contact the following registered representatives*:

Paul H. Carleton
phc@carletonmckenna.com
216.523.1962
Christopher J. McKenna
cjm@carletonmckenna.com
216.523.1962
Dominic M. Brault
dmb@carletonmckenna.com
216.523.1962

*Securities placed through Financial America Securities, Inc., which is a member of FINRA/SIPC

This entry was posted in News/Articles